Did COVID-19 lockdowns disrupt MS relapse care? study investigates
NCT ID NCT04858763
Summary
This study looked back to see if the first wave of the COVID-19 pandemic changed how people with multiple sclerosis (MS) reported and received care for their symptom flare-ups (relapses). Researchers compared 51 patients who had a relapse during April-June 2020 with a similar group from the same months in 2019. The goal was to understand if pandemic disruptions led to differences in seeking help or getting treatments like steroids.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nottingham University Hospitals NHS Trust
Nottingham, NG72UH, United Kingdom
Conditions
Explore the condition pages connected to this study.